Literature DB >> 10993828

Effects of midkine during in vitro maturation of bovine oocytes on subsequent developmental competence.

S Ikeda1, K Ichihara-Tanaka, T Azuma, T Muramatsu, M Yamada.   

Abstract

Midkine (MK) is known to be a member of a new family of heparin-binding growth/differentiation factors, together with pleiotrophin, and to be quite rich in bovine follicular fluid. To examine whether treatment with MK during in vitro maturation (IVM) of bovine granulosa-enclosed oocytes affects their nuclear maturation and postfertilization development to the blastocyst stage, bovine granulosa-enclosed oocytes obtained from slaughterhouse-derived ovaries were cultured for 24 h in IVM medium without (control) or with various concentrations (1-500 ng/ml) of MK, followed by in vitro fertilization (IVF) and culturing. Although the MK treatment during IVM did not affect the rate of nuclear maturation or the postfertilization cleavage of oocytes, MK at > or = 10 ng/ml significantly (P: < 0.05) increased the blastocyst yields per tested and per cleaved oocyte compared with the case of the control. Next, the effects of various glycosaminoglycans (heparin, heparan sulfate, chondroitin sulfate A and C, and hyaluronic acid) preincubated with MK at 50 ng/ml were examined. The enhancing activity of MK was completely suppressed by heparin at 600 ng/ml but not by the other compounds. The effects of MK during IVM were also tested on oocytes freed from granulosa cells (GCs). When the denuded oocytes were cultured in IVM medium, no blastocyst formation after IVF was observed, regardless of MK supplementation. However, coculture of the denuded oocytes with isolated GC pellets enhanced the cleavage rates and the blastocyst yield, and these effects were more pronounced with MK supplementation. These results indicate that the presence of MK during IVM of bovine granulosa-enclosed oocytes can enhance their developmental competence to the blastocyst stage after IVF and suggest that the enhancing effects might be mainly mediated by GCs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993828     DOI: 10.1095/biolreprod63.4.1067

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  11 in total

Review 1.  Structure and function of midkine as the basis of its pharmacological effects.

Authors:  T Muramatsu
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

2.  Ovarian brain-derived neurotrophic factor (BDNF) promotes the development of oocytes into preimplantation embryos.

Authors:  Kazuhiro Kawamura; Nanami Kawamura; Sabine M Mulders; Maarten D Sollewijn Gelpke; Aaron J W Hsueh
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-20       Impact factor: 11.205

Review 3.  Midkine and cytoplasmic maturation of mammalian oocytes in the context of ovarian follicle physiology.

Authors:  Shuntaro Ikeda; Masayasu Yamada
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

4.  Improving the maturation rate of human oocytes collected ex vivo during the cryopreservation of ovarian tissue.

Authors:  Dmitry Nikiforov; Cheng Junping; Jesus Cadenas; Vallari Shukla; Robert Blanshard; Susanne Elisabeth Pors; Stine Gry Kristensen; Kirsten Tryde Macklon; Lotte Colmorn; Erik Ernst; Anne-Mette Bay-Bjørn; Zeinab Ghezelayagh; Yu Wakimoto; Marie Louise Grøndahl; Eva Hoffmann; Claus Yding Andersen
Journal:  J Assist Reprod Genet       Date:  2020-02-24       Impact factor: 3.412

5.  CoQ10 increases mitochondrial mass and polarization, ATP and Oct4 potency levels, and bovine oocyte MII during IVM while decreasing AMPK activity and oocyte death.

Authors:  M K Abdulhasan; Q Li; J Dai; H M Abu-Soud; E E Puscheck; D A Rappolee
Journal:  J Assist Reprod Genet       Date:  2017-09-12       Impact factor: 3.412

Review 6.  Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases.

Authors:  Takashi Muramatsu
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493

Review 7.  Midkine: a promising molecule for drug development to treat diseases of the central nervous system.

Authors:  Takashi Muramatsu
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

8.  Retinol improves bovine embryonic development in vitro.

Authors:  Tracy Livingston; Dawn Eberhardt; J Lannett Edwards; James Godkin
Journal:  Reprod Biol Endocrinol       Date:  2004-12-21       Impact factor: 5.211

9.  In vitro maturation of ovine oocyte in a modified granulosa cells co-culture system and alpha-tocopherol supplementation: effects on nuclear maturation and cleavage.

Authors:  Hamideh Adeldust; Saeed Zeinoaldini; Hamid Kohram; Mahmoud Amiri Roudbar; Morteza Daliri Joupari
Journal:  J Anim Sci Technol       Date:  2015-08-14

10.  Bovine cumulus-granulosa cells contain biologically active retinoid receptors that can respond to retinoic acid.

Authors:  Mahesh Mohan; Nagaraja Ramavadhani Thirumalapura; Jerry Malayer
Journal:  Reprod Biol Endocrinol       Date:  2003-11-13       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.